Anula Jayasuriya - Net Worth and Insider Trading
Anula Jayasuriya Net Worth
The estimated net worth of Anula Jayasuriya is at least $10,500 dollars as of 2024-05-23. Anula Jayasuriya is the Director of Lineage Cell Therapeutics Inc and owns about 10,000 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $10,500. Details can be seen in Anula Jayasuriya's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Anula Jayasuriya has not made any transactions after 2023-12-29 and currently still holds the listed stock(s).
Transaction Summary of Anula Jayasuriya
Anula Jayasuriya Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Anula Jayasuriya owns 2 companies in total, including Lineage Cell Therapeutics Inc (LCTX) , and Jaguar Health Inc (JAGX) .
Click here to see the complete history of Anula Jayasuriya’s form 4 insider trades.
Insider Ownership Summary of Anula Jayasuriya
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LCTX | Lineage Cell Therapeutics Inc | 2023-12-29 | director |
| JAGX | Jaguar Health Inc | 2022-07-01 | director |
Anula Jayasuriya Latest Holdings Summary
Anula Jayasuriya currently owns a total of 1 stock. Anula Jayasuriya owns 10,000 shares of Lineage Cell Therapeutics Inc (LCTX) as of December 29, 2023, with a value of $10,500.
Latest Holdings of Anula Jayasuriya
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LCTX | Lineage Cell Therapeutics Inc | 2023-12-29 | 10,000 | 1.05 | 10,500 |
Holding Weightings of Anula Jayasuriya
Anula Jayasuriya Form 4 Trading Tracker
According to the SEC Form 4 filings, Anula Jayasuriya has made a total of 1 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lineage Cell Therapeutics Inc is the acquisition of 10,000 shares on December 29, 2023, which cost Anula Jayasuriya around $10,900.
Insider Trading History of Anula Jayasuriya
- 1
Anula Jayasuriya Trading Performance
GuruFocus tracks the stock performance after each of Anula Jayasuriya's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Anula Jayasuriya is 35.78%. GuruFocus also compares Anula Jayasuriya's trading performance to market benchmark return within the same time period. The performance of stocks bought by Anula Jayasuriya within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Anula Jayasuriya's insider trading performs compared to the benchmark.
Performance of Anula Jayasuriya
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.92 |  | | | | |
| Relative Return to S&P 500(%) | -2.39 | | | | | |
Anula Jayasuriya Ownership Network
Anula Jayasuriya Owned Company Details
What does Lineage Cell Therapeutics Inc do?
Who are the key executives at Lineage Cell Therapeutics Inc?
Anula Jayasuriya is the director of Lineage Cell Therapeutics Inc. Other key executives at Lineage Cell Therapeutics Inc include 10 percent owner Broadwood Partners Lp , Chief Financial Officer Jill Ann Howe , and director & President and CEO Brian M Culley .
Lineage Cell Therapeutics Inc (LCTX) Insider Trades Summary
Over the past 18 months, Anula Jayasuriya made 1 insider transaction in Lineage Cell Therapeutics Inc (LCTX) with a net purchase of 10,000. Other recent insider transactions involving Lineage Cell Therapeutics Inc (LCTX) include a net purchase of 6,730,770 shares made by Broadwood Partners Lp , a net purchase of 96,155 shares made by Don M Bailey ,
In summary, during the past 3 months, insiders sold 0 shares of Lineage Cell Therapeutics Inc (LCTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lineage Cell Therapeutics Inc (LCTX) were sold and 6,836,925 shares were bought by its insiders, resulting in a net purchase of 6,836,925 shares.
Lineage Cell Therapeutics Inc (LCTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lineage Cell Therapeutics Inc Insider Transactions
Anula Jayasuriya Mailing Address
Above is the net worth, insider trading, and ownership report for Anula Jayasuriya. You might contact Anula Jayasuriya via mailing address: 5150 El Camino Real, Suite #a-32, Los Altos Ca 94022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
